How Is Relapsing-Remitting MS Distinguished From Migraine?
At a Glance
Relapsing-remitting MS is distinguished from migraine and other causes of white-matter spots by the spots’ shape, location, and activity, whether symptoms match the MRI, and evidence of damage in different places and at different times. Blood tests or a spinal tap may help rule out mimics.
In this answer
4 sections
Finding out you have “spots” or white-matter lesions on your MRI can be alarming, but these spots are not unique to multiple sclerosis (MS). Doctors distinguish relapsing-remitting MS from other conditions by carefully analyzing the specific location, shape, orientation, and features of the lesions, and most importantly, by ensuring these imaging findings match your actual physical symptoms. MS is never diagnosed just by counting spots on a scan [1]. Instead, neurologists use a framework called the McDonald criteria to confirm that damage has occurred in different parts of the nervous system (dissemination in space) and at different times (dissemination in time), while systematically ruling out mimics like migraine, age-related changes, or other inflammatory disorders [2].
Note: Sudden-onset weakness, numbness, speech difficulty, severe imbalance, or vision loss warrants urgent medical assessment, as stroke and other emergencies can mimic demyelinating symptoms.
The Anatomy of an MS Lesion
To determine if a lesion is likely caused by MS, neuroradiologists look for specific characteristics:
- Shape and Orientation: MS lesions are often ovoid (egg-shaped). Classic MS lesions, known as Dawson’s fingers, radiate outward from the brain’s fluid-filled spaces (ventricles) at perpendicular angles [3] [4].
- Specific Locations: While many conditions cause spots deep in the brain, MS characteristically affects specific areas. These include the periventricular area (around the ventricles), the juxtacortical/cortical region (the U-fibers right beneath the brain’s surface and the cortex itself), the corpus callosum (the bridge between the two brain hemispheres), the infratentorial region (brainstem and cerebellum), the spinal cord, and the optic nerve [3] [2].
- Enhancement and Activity: By using a contrast dye called gadolinium, doctors can look for recent inflammation. Gadolinium enhancement indicates a temporary disruption in the blood-brain barrier, which usually reflects relatively recent inflammatory activity [1] [5]. Seeing both enhancing and non-enhancing lesions on a single scan can provide evidence of dissemination in time. However, a non-enhancing lesion is not necessarily “healed” or old, as scan timing and treatments like steroids can affect enhancement [6].
Differentiating MS from Common Mimics
Misinterpreting nonspecific white-matter spots is a recognized diagnostic pitfall [7]. Here are clues specialists use to distinguish MS from other potential causes:
Migraine and Small-Vessel Disease
Many people with a history of severe migraines have small, nonspecific white-matter spots on their MRIs. Similarly, small-vessel disease—which is highly associated with aging, high blood pressure, and smoking—causes lesions that can look like MS [8] [9].
Unlike MS, migraine and small-vessel lesions are usually punctate (tiny dots), are predominantly found in the deep subcortical white matter, and typically lack the classic Dawson’s finger shape [10]. Small-vessel disease may also present with microbleeds or small strokes (lacunes), which are not typical of MS [9]. However, these are clues rather than absolute rules, as severe small-vessel disease can occasionally mimic MS patterns.
Other Inflammatory Disorders (NMOSD and MOGAD)
Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are autoimmune diseases that can closely mimic MS but require different treatments.
- Spinal Cord and Optic Nerve Lesions: MS spinal cord lesions are usually short and located on the outer edges of the cord. In contrast, NMOSD often causes longitudinally extensive lesions that span three or more vertebral segments, as well as severe or bilateral optic nerve involvement [11] [4].
- Brain Lesions: MOGAD lesions are often described as poorly demarcated or “fluffy,” unlike the sharper ovoid lesions of MS [12].
Doctors use specific blood tests (anti-AQP4 and anti-MOG antibodies) to help identify these disorders, though results must always be interpreted alongside the clinical syndrome, as false positives and false negatives can occur.
Vitamin Deficiencies and Infections
- Metabolic/Nutritional: Deficiencies in vitamin B12 or copper can cause demyelination in the spinal cord. These often appear on an MRI as symmetric lesions in the back of the spinal cord (sometimes called an “inverted-V” sign), which is different from the typically asymmetric MS pattern [13] [14].
- Infections and Spinal Fluid Testing: Lyme disease, HIV, and other infections can occasionally cause neurological symptoms and brain spots. Depending on your risk factors and symptoms, doctors may run blood work or perform a spinal tap (lumbar puncture) [15]. A spinal tap is also highly valuable for finding oligoclonal bands or kappa free light chains—markers of immune activity in the cerebrospinal fluid that strongly support an MS diagnosis [16].
Advanced Imaging: Central Veins and Iron Rims
When the diagnosis is unclear, specialists may use powerful MRIs with specialized sequences to look for advanced supportive markers:
- The Central Vein Sign (CVS): Because MS lesions form around tiny blood vessels, specialized scans can sometimes detect a distinct central vein running through the middle of an MS lesion. Migraine and small-vessel disease lesions typically do not have this [17] [18].
- Paramagnetic Rim Lesions (PRLs): Some MS lesions develop a dark rim of iron on specialized imaging, indicating smoldering inflammation. Their presence is highly specific to MS and helps rule out mimics [19] [18].
It is important to know that these advanced markers are supportive, not definitive. They require specialized scanning protocols that aren’t available everywhere, they are not required to diagnose MS, and the absence of these markers does not rule out MS [18].
The Importance of Clinical Correlation
The phrase “treat the patient, not the scan” is critical in MS. Clinical correlation means that the spots on the MRI must make neuroanatomical sense given your physical symptoms [2]. For example, if you have new vision loss in your right eye, but your MRI only shows old, non-enhancing spots in the area of the brain that controls your legs, the MRI does not explain your current symptom.
If you have an atypical presentation—such as being older at symptom onset, having significant vascular risk factors, or having vague symptoms that don’t match standard MS relapses—it is highly recommended to seek a second opinion from an MS specialist or a neuroradiologist [7]. They can review your symptoms alongside your scans and determine if further testing or “watchful waiting” (monitoring with structured, scheduled follow-up MRIs) is the safest approach.
Common questions in this guide
What MRI features make white-matter spots more typical of MS than migraine?
Can the number of MRI spots by itself diagnose relapsing-remitting MS?
How can doctors tell MS lesions from migraine or small-vessel disease?
How important is it that my symptoms match the MRI findings?
What tests can look for conditions that resemble MS?
What do contrast enhancement and specialized MRI signs tell doctors?
When should sudden neurologic symptoms be treated as an emergency?
Related questions
Show more
Get notified when new evidence is published on relapsing-remitting multiple sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP, Goldschmidt CH, Rae-Grant AD
JAMA 2021; (325(8)):765-779 doi:10.1001/jama.2020.26858.
PMID: 33620411 - 2
Multiple Sclerosis Part 1: Essentials and the McDonald Criteria.
Gill S, Agarwal M
Magnetic resonance imaging clinics of North America 2024; (32(2)):207-220 doi:10.1016/j.mric.2023.11.002.
PMID: 38555137 - 3
Clinical integration of brain and cord MRI features improves differential diagnosis of multiple sclerosis.
Rocca MA, Ratzinger S, Preziosa P, et al.
Journal of neurology 2025; (272(6)):388 doi:10.1007/s00415-025-13124-x.
PMID: 40349257 - 4
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Clarke L, Arnett S, Bukhari W, et al.
Frontiers in neurology 2021; (12()):722237 doi:10.3389/fneur.2021.722237.
PMID: 34566866 - 5
Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns.
Metz I, Gavrilova RH, Weigand SD, et al.
Annals of neurology 2021; (90(3)):440-454 doi:10.1002/ana.26163.
PMID: 34231919 - 6
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.
Absinta M, Sati P, Schindler M, et al.
The Journal of clinical investigation 2016; (126(7)):2597-609.
PMID: 27270171 - 7
Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.
Solomon AJ, Naismith RT, Cross AH
Neurology 2019; (92(1)):26-33 doi:10.1212/WNL.0000000000006583.
PMID: 30381369 - 8
Antithrombin deficiency caused by SERPINC1 gene mutation in white matter lesions: A case report.
Wang S, He R, Xia J, et al.
Medicine 2024; (103(14)):e37721 doi:10.1097/MD.0000000000037721.
PMID: 38579030 - 9
Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia.
Hainsworth AH, Markus HS, Schneider JA
Hypertension (Dallas, Tex. : 1979) 2024; (81(1)):75-86 doi:10.1161/HYPERTENSIONAHA.123.19943.
PMID: 38044814 - 10
The dilemma of bright spots detected on magnetic resonance imaging of the brain for the diagnosis of multiple sclerosis: A retrospective evaluation of nonspecific white matter lesions.
Tutar NK, Omerhoca S, Soylemez E, et al.
Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi 2024; (37(2)):94-101 doi:10.14744/DAJPNS.2024.00244.
PMID: 42460277 - 11
Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clarke L, Arnett S, Lilley K, et al.
Clinical and experimental immunology 2021; (206(3)):251-265 doi:10.1111/cei.13630.
PMID: 34080180 - 12
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.
Sechi E, Cacciaguerra L, Chen JJ, et al.
Frontiers in neurology 2022; (13()):885218 doi:10.3389/fneur.2022.885218.
PMID: 35785363 - 13
Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies.
Weidauer S, Wagner M, Nichtweiß M
Clinical neuroradiology 2017; (27(4)):417-433 doi:10.1007/s00062-017-0604-x.
PMID: 28667382 - 14
A Case of Idiopathic Hypocupric Myeloneuropathy.
Addepalli S, Nirhale S, Rohatgi S, et al.
Annals of African medicine 2026; (25(Suppl 3)):S471-S473 doi:10.4103/aam.aam_626_25.
PMID: 42487296 - 15
Imaging in Lyme neuroborreliosis.
Lindland ES, Solheim AM, Andreassen S, et al.
Insights into imaging 2018; (9(5)):833-844 doi:10.1007/s13244-018-0646-x.
PMID: 30187265 - 16
Diagnostic evolution in multiple sclerosis: A narrative review of the McDonald criteria from 2001 to 2024.
Agrawal M, Sridhar S, Surendran AK, et al.
Multiple sclerosis and related disorders 2025; (104()):106756 doi:10.1016/j.msard.2025.106756.
PMID: 41101247 - 17
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.
Cagol A, Cortese R, Barakovic M, et al.
JAMA neurology 2024; (81(2)):143-153 doi:10.1001/jamaneurol.2023.4737.
PMID: 38079177 - 18
Implementing the 2024 revision of the McDonald diagnostic criteria for multiple sclerosis in Germany: Practical considerations and consensus recommendations.
Wattjes MP, Bayas A, Bittner S, et al.
Therapeutic advances in neurological disorders 2026; (19()):17562864261481602 doi:10.1177/17562864261481602.
PMID: 42662141 - 19
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Meaton I, Altokhis A, Allen CM, et al.
Multiple sclerosis (Houndmills, Basingstoke, England) 2022; (28(14)):2212-2220 doi:10.1177/13524585221118677.
PMID: 36017870
This page is for informational purposes only and does not constitute medical advice. A neurologist should interpret your MRI, symptoms, and test results; sudden neurologic symptoms require urgent medical assessment.